Literature DB >> 22003207

Pivotal Advance: Invariant NKT cells reduce accumulation of inflammatory monocytes in the lungs and decrease immune-pathology during severe influenza A virus infection.

Wai Ling Kok1, Laura Denney, Kambez Benam, Suzanne Cole, Colin Clelland, Andrew J McMichael, Ling-Pei Ho.   

Abstract

Little is known of how a strong immune response in the lungs is regulated to minimize tissue injury during severe influenza A virus (IAV) infection. Here, using a model of lethal, high-pathogenicity IAV infection, we first show that Ly6C(hi)Ly6G(-) inflammatory monocytes, and not neutrophils, are the main infiltrate in lungs of WT mice. Mice devoid of iNKT cells (Jα18(-/-) mice) have increased levels of inflammatory monocytes, which correlated with increased lung injury and mortality (but not viral load). Activation of iNKT cells correlated with reduction of MCP-1 levels and improved outcome. iNKT cells were able to selectively lyse infected, MCP-1-producing monocytes in vitro, in a CD1d-dependent process. Our study provides a detailed profile and kinetics of innate immune cells in the lungs during severe IAV infection, highlighting inflammatory monocytes as the major infiltrate and identifying a role for iNKT cells in control of these cells and lung immune-pathology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22003207     DOI: 10.1189/jlb.0411184

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  48 in total

1.  Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages.

Authors:  Christophe Paget; Stoyan Ivanov; Josette Fontaine; Joelle Renneson; Fany Blanc; Muriel Pichavant; Laure Dumoutier; Bernhard Ryffel; Jean Christophe Renauld; Philippe Gosset; Pierre Gosset; Mustapha Si-Tahar; Christelle Faveeuw; François Trottein
Journal:  J Biol Chem       Date:  2012-01-31       Impact factor: 5.157

Review 2.  How the Respiratory Epithelium Senses and Reacts to Influenza Virus.

Authors:  Kambez H Benam; Laura Denney; Ling-Pei Ho
Journal:  Am J Respir Cell Mol Biol       Date:  2019-03       Impact factor: 6.914

Review 3.  Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions.

Authors:  Patrick J Brennan; Manfred Brigl; Michael B Brenner
Journal:  Nat Rev Immunol       Date:  2013-01-21       Impact factor: 53.106

4.  Inflammatory mechanisms in sepsis: elevated invariant natural killer T-cell numbers in mouse and their modulatory effect on macrophage function.

Authors:  Daithi S Heffernan; Sean F Monaghan; Rajan K Thakkar; Mai L Tran; Chun-Shiang Chung; Stephen H Gregory; William G Cioffi; Alfred Ayala
Journal:  Shock       Date:  2013-08       Impact factor: 3.454

5.  Pseudotyped influenza A virus as a vaccine for the induction of heterotypic immunity.

Authors:  Timothy J Powell; Jonathan D Silk; Jane Sharps; Ervin Fodor; Alain R M Townsend
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

Review 6.  Role of T cell immunity in recovery from influenza virus infection.

Authors:  Jie Sun; Thomas J Braciale
Journal:  Curr Opin Virol       Date:  2013-05-27       Impact factor: 7.090

Review 7.  Tissue-specific functions of invariant natural killer T cells.

Authors:  Catherine M Crosby; Mitchell Kronenberg
Journal:  Nat Rev Immunol       Date:  2018-09       Impact factor: 53.106

Review 8.  Understanding the Host Innate Immune Responses against SARS-CoV-2 Infection and COVID-19 Pathogenesis.

Authors:  Yeon-Woo Kang; Subin Park; Kun-Joo Lee; Dain Moon; Young-Min Kim; Seung-Woo Lee
Journal:  Immune Netw       Date:  2021-02-26       Impact factor: 6.303

Review 9.  Invariant NKT cells: regulation and function during viral infection.

Authors:  Jennifer A Juno; Yoav Keynan; Keith R Fowke
Journal:  PLoS Pathog       Date:  2012-08-16       Impact factor: 6.823

10.  Unaltered influenza disease outcomes in swine prophylactically treated with α-galactosylceramide.

Authors:  Weihong Gu; Darling Melany D Madrid; Guan Yang; Bianca L Artiaga; Julia C Loeb; William L Castleman; Jürgen A Richt; John A Lednicky; John P Driver
Journal:  Dev Comp Immunol       Date:  2020-08-29       Impact factor: 3.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.